Haematology 2018
GHSG HD10 Clinical Trial Weakest vs strongest arm (FFTF)
HD10, arms A v s. D (ITT)
1.0
0.9
0.8
0.7
0.6
0.5
0.4
Arm difference in 5-year-FFTF -1,6% 95% CI [-6,3%; 3,1%]
0.3
0.2
Freedom from Treatment Failure
0.1
A
D
0.0
Freedom from Treatment Failure
0
12
24
36
48
60
72
84
96
108
120
Time [months]
Pts. at Risk
Time (months)
A D
298 299
277 275
264 265
255 252
239 239
217 199
167 151
121 110
74 66
35 28
3 4
Engert A et al; NEJM 2010
Made with FlippingBook - professional solution for displaying marketing and sales documents online